[ACRX] QoQ Quarter Result on 31-Mar-2012 [#Q1]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
08-May-2012
Financial Year
2012
Quarter
31-Mar-2012 [#Q1]
Profit Trend
QoQ- -10.88%
YoY- -120.51%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
Revenue 1,675 166 224 329 624 408 40 1092.30%
PBT -33,363 -8,582 -6,596 -7,065 -20,101 -5,761 -4,607 272.07%
Tax -22,841 390 248 519 -13,728 356 144 -
NP -10,522 -8,582 -7,194 -7,065 -6,372 -5,761 -4,763 69.21%
Tax Rate - - - - - - - -
Total Cost 12,197 8,748 7,418 7,394 6,996 6,169 4,803 85.60%
Ratio Analysis
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
NP Margin -628.18 -5,169.88 -3,211.61 -2,147.42 -1,021.15 -1,412.01 -11,907.50 -85.80%
Per Share
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
EPS -5.67 -7.58 -6.98 -7.21 -6.50 -5.92 -4.92 9.87%
EPS Diluted -5.67 -7.58 -6.98 -7.21 -6.50 -5.92 -4.92 9.87%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.